MapLight Therapeutics MPLT
NASDAQ MPLT
$8.25 +0.09 (+1.10%)
At close: Oct 22, 2026 · 4:00 PM EDT

MapLight Therapeutics (MPLT) Operating Income (2024 - 2026)

Updated

MapLight Therapeutics' Operating Income was -$63.55 million in Q2 2026, compared with -$30.66 million a year earlier.

Analysis

MapLight Therapeutics (MPLT) Operating Income (2024 - 2026) Analysis & Trends

On a trailing twelve-month basis, MapLight Therapeutics' Operating Income was -$209.09 million through Jun 30, 2026; for FY2025, it was -$169.08 million.

  • In earlier years, Operating Income was -$82.95 million in FY2024.
  • Quarterly Operating Income has moved between -$83.38 million (Q4 2025) and -$20.89 million (Q3 2024) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 11.75 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 6.18 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 6.43 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -584.00 Mn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 3.16 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 3.51 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -10.39 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 4.27 Bn
10 MapLight Therapeutics 374.85 Mn 70.13 Mn - -63.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -63.55 Mn
Dec 31, 2025 -83.38 Mn
Sep 30, 2025 -31.50 Mn
Jun 30, 2025 -30.66 Mn
Dec 31, 2024 -22.78 Mn
Sep 30, 2024 -20.89 Mn
API Access

MapLight Therapeutics Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=MPLT&period=max&api_key=YOUR_API_KEY